share_log

HC Wainwright & Co. Maintains Buy on BioNTech, Raises Price Target to $113

Benzinga ·  May 8 07:20

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and raises the price target from $107 to $113.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment